title: Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC).
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, NY.
authors.forename: S C
authors.initials: SC
authors.lastname: Gulati
authors.forename: J
authors.initials: J
authors.lastname: Gaynor
authors.forename: I
authors.initials: I
authors.lastname: Esseesse
authors.forename: T
authors.initials: T
authors.lastname: Gee
authors.forename: C
authors.initials: C
authors.lastname: Little
authors.forename: M
authors.initials: M
authors.lastname: Andreeff
authors.forename: E
authors.initials: E
authors.lastname: Berman
authors.forename: S
authors.initials: S
authors.lastname: Kempin
authors.forename: B
authors.initials: B
authors.lastname: Clarkson
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D012044:Regression Analysis; D012074:Remission Induction; D012307:Risk Factors